In the ninth part of this roundtable discussion, industry experts discuss how the pharma supply chain is evolving into an ...

Addressing the most common concerns surrounding the legislation intended to establish interoperability within the pharma ...

A federal judge tripled damages against the pharmacy benefits manager after finding it encouraged inflated Medicare drug ...

This episode of Pharma Pulse covers the White House–EU agreement on pharmaceutical tariffs, Johnson & Johnson’s $2 billion ...

Ron Lanton, partner, Lanton Law, explains that declining public trust and political support for vaccines could force pharmaceutical companies to rethink regulatory strategies and investment priorities ...